LUTATHERA 370 MBq/ml, solution for infusion bottle
Active ingredients: LUTÉCIUM (177LU) OXODOTRÉOTIDE
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for infusionbottleintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LUTATHERA 370 MBq/ml, solution pour perfusion
- Pharmaceutical form
- solution pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre de 20,5 à 25,0 mL de solution
- Marketing authorisation holder
- NOVARTIS EUROPHARM (IRLANDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 11 Jan 2018
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60823764CIP75504433CIP133400955044338Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LUTÉCIUM (177LU) OXODOTRÉOTIDEsolution | 370 MBq à la date et à l’heure de calibration · 1 mL de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.